The emergence of Neisseria meningitidis serogroup X (NmX) in the African meningitis belt, 25 urged the development of diagnostic tools and vaccines for this serogroup, especially following 26 the introduction of a conjugate vaccine against meningococci serogroup A (NmA). We have 27 developed and evaluated a new rapid diagnostic test (RDT) for detecting the capsular 28 polysaccharide (cps) antigen of this emerging serogroup. Whole inactivated NmX bacteria were 29 used to immunize rabbits. Following purification by affinity chromatography, the cpsX-specific 30 IgG antibodies, were utilized to develop a NmX-specific immunochromatography dipstick RDT.
INTRODUCTION
Neisseria meningitidis (Nm) is an exclusively human capsulated bacterium that can provoke 50 severe invasive infections such as meningitis and septicaemia (1) . Meningococcal disease is still 51 a major public health concern due to potential epidemic spread. While the disease occurs 52 sporadically in Europe and North America, it is responsible for major recurrent epidemics within 53 the African meningitis belt (2). The bacterial capsular polysaccharide determines the 12 Nm (mainly serogroups W (NmW) and X (NmX)), were also detected and still are. Of particular 65 concern, outbreaks due to isolates of NmW and NmX were recently reported in Africa (7-9). 66 Surveillance of the distribution of meningococcal serogroups is therefore important and its 67 comprehensiveness will benefit from diagnosis tools that can be widely used at bedside. We 
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The PCR analysis of these samples was used as a reference method to detect N. meningitidis, 113 Streptococcus pneumoniae and Haemophilus influenzae, as well as to genogroup meningococcus-114 positive specimens. PCR conditions and primers were as previously described (8). Culture was 115 not used as it has been constantly shown to be less sensitive than PCR (18). Culture data were 116 available only for 26 of the 369 tested CSF samples. The capsular polysaccharide of serogroup X (cpsX) was purified from the NmX strain 19504 120 (that gave the highest yield when cultured on GCB medium with Kellogg supplements) by the 121 Cetavlon extraction method as previously described (19) . Briefly, bacteria (1 L) at late-122 logarithmic phase of growth were formaldehyde-inactivated (1% v/v) and then treated with 123 Cetavlon (0.1% w/v) (Sigma Aldrich, France). After centrifugation, the pellet was dissolved in 124 cold aqueous CaCl 2 (0.9M). The solubilised materials were cleared by precipitation in 25% 125 aqueous ethanol and the remaining supernatant was precipitated by 80% aqueous ethanol. The 126 pellet was dissolved in phosphate buffer (Na 2 HPO 4 , NaH 2 PO 4 , 0.2 M) and treated with Dnase Table 1 ).
140

Rabbit immunization and purification of specific anti-cpsX IgG antibodies 141
Two New Zealand White female rabbits (3 kg) were immunised intravenously three times with 142 doses of 1mL of a suspension of 10 9 colony forming units, CFU, of freshly heat-inactivated 143 7 NmX strain 19504 (30 min at 56°C), at day 0, 7 and 21. Sera were taken before immunization 144 and at day 28 after the fist injection to evaluate the immune response by ELISA (see below). Dot 145 blotting with rabbit sera (1:1000 serum dilution) was performed using Amersham ECL kits (GE 146 Healthcare Life Sciences Velizy-Villacoublay, France) as previously described (21). Rabbit 
RESULTS
192
Characterization of rabbit anti-meningococcal serogroup X rabbit serum 193 Following the three dose-immunization regimen with whole NmX bacteria, the rabbit sera 194 were tested in dot blot analysis against spotted bacteria. While no bacteria detection was obtained 195 with control pre-immune sera, a strong detection was obtained with the sera from immunized 196 rabbits ( Fig.1) . Sera from the two responding rabbits were pooled and anti-cpsX-specific IgG (Fig. 2B ).
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A dipstick rapid diagnostic test for NmX was produced (see Material and Methods), and its 204 detection limits were established. For the purified cpsX, this limit was 1 ng/mL ( Fig. 2C ) and 205 was 10 5 CFU/mL (data not shown) for NmX bacteria (strain 19504) The cut-off analysis was 206 repeated 3 times with identical findings that were not affected by dipstick storage for 3 weeks at 207 25°C. We also tested the RDT on a collection of bacterial suspension (Table 1) at 10 6 CFU/mL.
208
Only the serogroup X isolates were detectable (data not shown). As different concentrations of 209 antibodies were used in these assays, the data suggest that the concentrations of antibodies do not 210 preclude detectable reactivity with other serogroups. NmX-specific RDT (data not shown). 232 We also conducted a limited prospective analysis during the epidemic season 2014 in the three 233 laboratories located in countries of the meningitis belt. We tested all the 153 CSF samples that Table 3 . The specificity of RDT for CSF 244 infected by NmX was 100%, while the sensitivity reached 94%. Calculating the positive 245 likelihood LR + and DOR was not feasible due to a Sp value of 100%. LR + and DOR values were 246 therefore calculated using a value for the specificity that corresponded to the lower 95% 247 confidence interval for specificity (0.99) ( Table 3) .
248
The prevalence of NmX among the 369 tested CSF was 25%. Therefore, the NPV and PPV are 249 given in Table 3 under this prevalence value. However, the tested samples were selected from the 250 collections of the participating laboratories and may not reflect the real prevalence of the disease.
251
Moreover, the frequency of NmX meningitis may also vary across time and countries within the 252 meningitis belt and elsewhere. We therefore calculated the negative and positive predictive 253 values (NPV and PPV) according to a prevalence varying from 0 to 100%, using the Se and Sp 254 obtained from the CSF samples in this study (Fig. 3) . (Table 3) .
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We also evaluated its usefulness that depends not only on the quality of the test but also 287 on the prevalence of the NmX meningitis in the tested population. The prevalence of NmX within 288 the panel of CSF samples that was used to evaluate the RDT specificity and sensitivity was 289 25.7%. It may not properly reflect the real prevalence of NmX in areas at risk. Usefulness is 290 usually evaluated using two parameters, the PPV and NPV. When NmX prevalence was forced to 291 vary between 0 and 100%, the PPV remained stable at 1 indicating that the test remained highly 
